Home » Products » Reagent Center » Rapid Test Kits » Tumor Markers » CA15-3 Rapid Test Kit (Immunochromatographic Assay)

loading

Share to:
facebook sharing button
twitter sharing button
line sharing button
wechat sharing button
linkedin sharing button
pinterest sharing button
sharethis sharing button

CA15-3 Rapid Test Kit (Immunochromatographic Assay)

CA15-3 Rapid Test Kit is used to detect Cancer Antigen CA15-3 in human samples, and mainly used in Clinical Observation of Therapeutic Efficary and Prognosis of Breast Cancer.
1 Box:
Availability:
Quantity:
  • ICA2409

  • Bioteke

CA15-3 Rapid Test Kit (Immunochromatographic Assay)

For PROFESSIONAL USE ONLY



INTENDED USE

  • It is used to detect cancer antigen 15-3(CA15-3) in human samples,and is mainly used in dinical observation of therapeutic efficacy and prognosis of breast cancer.

  • Breast cancer is the most frequently diagnosed cancer among women, and also the cancer with the highest mortality rate among women. It is a disease in which abnormal breast cells grow out of control and form tumors. After active and effective comprehensive treatment, most patients can be cured and recover well. But if not detected and treated in a timely manner, it can lead to cancer cell metastasis, worsening of the condition, affecting the patient's quality of life,and even lifespan.

  • Cancer antigen 15-3(CA15-3), a glycoprotein, is the most common tumor marker of breast cancer. CA15-3 increased in 30-50% of breast cancer patients and 80% of patients with metastasis. Its clinical significance includes the following:

1. For early auxiliary diagnosis of breast cancer metastasis: CA15-3 is more sensitive than carcinoembryonic antigen and tissue polypeptide antigen in detecting cancer metastasis and it is earlier than cinical detection of metastasis.

2. For postoperative evaluation of breast cancer: CA15-3 can also monitor the recurrence of patients after surgery, especially the important quota of postoperative monitoring for cancer metastasis patients. The increase of serum CA15-3 level indicates local or systemic recurrence of breast cancer, and the increase is earlier than the radionuclide examination and clinical examination; Used for follow-up evaluation of treatment and early detection of metastatic lesions, the increase of CA15-3 is several months earlier than the clinical diagnosis of metastatic lesions.

In addition to the increase of CA15-3 in serum samples of breast cancer patients, the increase of serum CA15-3 may also occur in patients with other tumors, such as lung cancer, ovarian cancer, colon cancer, liver cancer, etc.

In addition, non malignant tumor diseases such as benign breast diseases and ovarian diseases can also cause an increase in CA15-3 levels. 

CA15-3 rapid test

CA15-3 Rapid Test Kit



CA15-3 rapid test kit

CA15-3 Rapid Test Kit


DETECTION PRINCIPLE

This kit is an immunochromatographic kit that uses a doubleantibody sandwich method to detect CA15-3 in human blood samples.


STORAGE & SHELFLIFE

  • Room temperature at 2-30℃.

  • Valid for 24 months.

  • Not frozen.

  • Keep dry and away from sunlight.


CERTIFICATE

ce mark.


RELATED PRODUCTS

AFP rapid test kit

Tumor Marker AFP test

HE4 rapid test kit

Tumor Marker HE4 test

NSE rapid test kit

Tumor Marker NSE test


Previous: 
Next: 
QUICK LINKS
PRODUCT CENTER
CONTACT US
Placeholder Image

   Telephone/Whatsapp: +86 18115363743

Placeholder Image

  Email : zr@bioteke.cn

Copyright BioTeke Corporation(wuxi) Co.,Ltd  |   苏ICP备18042459号-1